Dana dhuwit saben siji saham Adlai Nortye (ANL)

Simbol lan logo merek Adlai Nortye Limited (ANL)

Adlai Nortye Ltd. (ANL) is attracting investment through the development of PI3K inhibitors that could become the gold standard for treating resistant cancer. The trend in liquid assets per share illustrates financial stability, where the 4.00 level reflects the status of the parameter. However, the business relies on full outsourcing for synthesis and trials, while regulatory pressure between China and the US, combined with costly research, creates risks of capital shortages.

ANL adlainortye.com: Dana dhuwit saben saham ing interval 21.02.2024 - 20.11.2026

Rincian analitis perusahaan Adlai Nortye Ltd (ANL)

- rega saham lan prakiraan rega para ahli:
- data dhuwit lan arus kas:
Ringkesan analisis perusahaan:ANL (Adlai Nortye Limited)
Produk dadi Adlai Nortye

Professional managers utilize fundamental metrics to filter assets based on internal liquidity levels. This indicator determines the share of net cash reserves per security, reflecting the business's solvency. For Adlai Nortye Ltd. (ANL), this resource is critical for financing the final stages of buparlisib trials and preparing documentation for the FDA. While excess funds guarantee stability, they may signal low capital efficiency. By analyzing the cash per share metric, an investor assesses the company's margin of safety prior to drug commercialization.

Perusahaan pesaing

Dana dhuwit saben siji saham ONC (BeiGene Corp)|Dhuwit awis saben siji saham HALO (Halozyme Therapeutics, Inc.)|Dhuwit awis saben saham Revolution Medicines, Inc. (RVMD)|Dhuwit awis saben saham AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cekelan dhuwit saben saham|URGN - Dana dhuwit saben saham|Bicara Bio - Dhuwit awis diétung saben siji saham|PSNL: Dhuwit awis saben saham|Dana dhuwit saben siji saham ERAS|Dhuwit awis saben siji saham DCTH|Cekelan dhuwit saben saham Y-mAbs Therapeutics Inc YMAB|Dhuwit awis saben saham AURA|CADL (Candel Therapeutics, Inc.) - Gunggung dhuwit awis saben saham|Dana dhuwit saben saham Accuray Inc ARAY|Dana dhuwit diétung saben saham SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Citius Oncology|HURA: Dhuwit awis saben saham|Dhuwit awis saben lembar saham TARA (Protara)|FATE (fatetherapeutics.com) - Dhuwit awis saben saham|Cekelan dhuwit saben saham Aadi Bioscience WHWK|Dhuwit awis saben saham TCRX|CSBR - Cekelan dhuwit saben saham|XBiotech - Dhuwit awis saben siji saham|CEL-SCI Corporation (CVM) - Cekelan dhuwit saben saham|OSTX - Dana dhuwit saben saham|Cekelan dhuwit saben saham Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Dhuwit awis saben siji saham|Veru Pharma - Gunggung dhuwit awis saben saham|Dana dhuwit saben saham Tempest Therapeutics Corp|Dana dhuwit saben siji saham XLO (Xilio Therapeutics, Inc.)|Dhuwit awis saben saham RENB|MURA (Mural Oncology) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham KAPA (Kairos Pharma Ltd)|OKUR: Dana dhuwit saben siji saham|GDTC: Dhuwit awis saben siji saham|CRIS - Dhuwit awis saben saham|APLM: Dhuwit awis saben saham|Cekelan dhuwit saben saham tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Dhuwit awis saben saham|Dhuwit awis saben saham Genprex Inc.|Dhuwit awis saben saham CLDI|Dhuwit awis saben siji saham Sunshine Biopharma, Inc. SBFM|Dhuwit awis saben saham XBIO (Xenetic Biosciences)|Gunggung dhuwit awis saben saham SLRX|PPBT - Dana dhuwit saben saham|AONC (aoncology.com) - Dana dhuwit saben siji saham|BGNE: Dhuwit awis saben saham|Checkpoint Therapeutics Inc (CKPT) - Dhuwit awis saben saham|ELEV (Elevation Oncology Inc.) - Dhuwit awis saben saham|icadmed.com (ICAD) - Dana dhuwit diétung saben saham|Dhuwit awis saben saham IKNA|NTBL (Notable Labs) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham VIRX (Viracta Therapeutics)|Dana dhuwit diétung saben saham MorphoSys AG (MOR)|NAYA Biosciences Corp - Dhuwit awis saben saham|Cekelan dhuwit saben saham ascentage.com